BSE Live
Apr 10, 16:01Prev. Close
255.00
Open Price
257.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 10, 15:59Prev. Close
254.91
Open Price
254.78
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Nureca (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -0.46 | -3.27 | -10.96 | 61.33 | 62.49 | |
| Net CashFlow From Operating Activities | -18.55 | -3.00 | 12.05 | 1.83 | 35.10 | |
| Net Cash Used In Investing Activities | 8.56 | 17.84 | -18.30 | -3.37 | -110.48 | |
| Net Cash Used From Financing Activities | -0.79 | -1.28 | -1.51 | -7.30 | 92.34 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -10.77 | 13.56 | -7.76 | -8.84 | 16.96 | |
| Cash And Cash Equivalents Begin of Year | 13.96 | 0.40 | 8.16 | 17.00 | 0.04 | |
| Cash And Cash Equivalents End Of Year | 3.19 | 13.96 | 0.40 | 8.16 | 17.00 |
20.01.2026
Nureca Consolidated December 2025 Net Sales at Rs 39.64 crore, up 49.8% Y-o-Y
19.01.2026
Nureca Standalone December 2025 Net Sales at Rs 39.64 crore, up 45.69% Y-o-Y
17.10.2025
Nureca Consolidated September 2025 Net Sales at Rs 37.74 crore, up 21% Y-o-Y
17.10.2025
Nureca Standalone September 2025 Net Sales at Rs 37.84 crore, up 16.9% Y-o-Y
20.01.2026
Nureca Consolidated December 2025 Net Sales at Rs 39.64 crore, up 49.8% Y-o-Y
19.01.2026
Nureca Standalone December 2025 Net Sales at Rs 39.64 crore, up 45.69% Y-o-Y
17.10.2025
Nureca Consolidated September 2025 Net Sales at Rs 37.74 crore, up 21% Y-o-Y
17.10.2025
Nureca Standalone September 2025 Net Sales at Rs 37.84 crore, up 16.9% Y-o-Y
23.05.2024
Stock Radar: Power Grid, Nykaa, Gland Pharma, Go Digit, Granules India in focus on Thursday
22.05.2024
15.05.2024
30.11.2022